Guide to Biosimilars Litigation and Regulation in the U.S., 2019-2020 ed. - Couverture souple

Goodwin

 
9781539286721: Guide to Biosimilars Litigation and Regulation in the U.S., 2019-2020 ed.
Couverture souple
ISBN 10 : 153928672X ISBN 13 : 9781539286721
Editeur : Thomson Reuters, 2019

Synopsis

Guide to Biosimilars Litigation and Regulation in the U.S. is an understandable guide and go-to reference, providing expert and practical guidance for attorneys working in this burgeoning area of the law.

The title explores each section of the Biologics Price Competition and Innovation Act (BPCIA) as well as an overview of legal and regulatory issues unique to biosimilars that have arisen or are expected to arise in litigation concerning biosimilar products.

This resource also includes discussion of the 20+ cases making their way through the judicial system.

Related statutes and regulations, agency guidance, and other relevant materials are included in the extensive appendices.

Les informations fournies dans la section « Synopsis » peuvent faire référence à une autre édition de ce titre.

Éditeur
Thomson Reuters
Date d'édition
2019
Langue
anglais
ISBN 10 
153928672X
ISBN 13 
9781539286721
Reliure
Taschenbuch
Nombre de pages
708
Coordonnées du fabricant
non disponible
Personne responsable
non disponible